SEARCH

SEARCH BY CITATION

Acknowledgements

This work was supported by grant DA 08379 from the National Institute on Drug Abuse (to M.E.A.R.).

  • 1
    Amejdki-Chab N., Benmansour S., Costentin J. & Bonnet J. -J. (1992a) Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783 : attempts to characterize the Na+ dependence of the neuronal transport of dopamine.J. Neurochem. 59,17951804.
  • 2
    Amejdki-Chab N., Costentin J. & Bonnet J. -J. (1992b) Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783.J. Neurochem. 58,793800.
  • 3
    Billaud G., Costentin J. & Bonnet J. -J. (1993) Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes. Eur. J. Pharmacol. 247,333340.
  • 4
    Bonnet J., Benmansour S., Vaugeois J. & Costentin J. (1998) Ionic requirements for the specific binding of [3H]GBR 12783 to a site associated with the dopamine uptake carrier. J. Neurochem. 50,759765.
  • 5
    Buck K.J. & Amara S.G. (1995) Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.Mol. Pharmacol. 48,10301037.
  • 6
    Chen N., Ding J., Wang Y. & Reith M.E.A. (1997a) Modeling of the interaction of Na+ and K+ with the binding of the cocaine analogue 3β-([125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester to the dopamine transporter. J. Neurochem. 68,19681981.
  • 7
    Chen N., Wang Y. & Reith M.E.A. (1997b) Binding of [125I]3β-(iodophenyl)tropan-2β-carboxylic acid isopropyl ester to the dopamine transporter at a physiologically relevant temperature : mutually exclusive binding and different ionic requirement for various uptake blockers and substrates. Synapse 25,155162.
  • 8
    Edvardsen O. & Dahl S.G. (1994) A putative model of the dopamine transporter.Mol. Brain Res. 27,265274.
  • 9
    Ehlert F.J. (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.Mol. Pharmacol. 33,187194.
  • 10
    Eshleman A.J., Calligaro D.O. & Eldefrawi M.E. (1993) Allosteric regulation by sodium of the binding of [3H]cocaine and [3H]GBR 12935 to rat and bovine striata. Membr. Biochem. 10,129144.
  • 11
    Eshleman A.J., Henningsen R.A., Neve K.A. & Janowsky A. (1994) Release of dopamine via the human transporter.Mol. Pharmacol. 45,312316.
  • 12
    Eshleman A.J., Neve R.L., Janowsky A. & Neve K.A. (1995) Characterization of a recombinant human dopamine transporter in multiple cell lines.J. Pharmacol. Exp. Ther. 274,276283.
  • 13
    Eshleman A.J., Stewart E., Evenson A.K., Mason J.N., Blakely R.D., Janowsky A. & Neve K.A. (1997) Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J. Neurochem. 69,14591466.
  • 14
    Giros B., Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T. & Caron M.G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.Mol. Pharmacol. 42,383390.
  • 15
    Giros B., Wang Y.M., Suter S., McLeskey S.B., Pifl C. & Caron M.G. (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters.J. Biol. Chem. 269,1598515988.
  • 16
    Gu H.H. & Rudnick G. (1996) A thermodynamic study of the dopamine transporter ion-coupling mechanism.Soc. Neurosci. Abstr. 22,370.
  • 17
    Gu H., Wall S.C. & Rudnick G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.J. Biol. Chem. 269,71247130.
  • 18
    Harris J.E. & Baldessarini R.J. (1973) The uptake of (3H)dopamine by homogenates of rat corpus striatum : effects of cations. Life Sci. 13,303312.
  • 19
    Héron C., Billaud G., Costentin J. & Bonnet J. -J. (1996) Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier. Eur. J. Pharmacol. 301,195202.
  • 20
    Holz R.W. & Coyle J.T. (1974) The effect of various salts, temperature, and the alkaloids veratridine and batrachotoxin on the uptake of [3H]dopamine into synaptosomes from rat striatum. Mol. Pharmacol. 10,746758.
  • 21
    Humphreys C.J., Wall S.C. & Rudnick G. (1994) Ligand binding to the serotonin transporter : equilibria, kinetics, and ion dependence.Biochemistry 33,91189125.
  • 22
    Kitayama S., Shimada S., Xu H., Markham L., Donovan D.M. & Uhl G.R. (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.Proc. Natl. Acad. Sci. USA 89,77827785.
  • 23
    Mager S., Min C., Henry D.J., Chavkin C., Hoffman B.J., Davidson N. & Lester H.A. (1994) Conducting states of a mammalian serotonin transporter.Neuron 12,845859.
  • 24
    McElvain J.S. & Schenk J.O. (1992) A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine.Biochem. Pharmacol. 43,21892199.
  • 25
    Meiergerd S.M., Hooks S.M. & Schenk J.O. (1994) The striatal transporter for dopamine in the rat may be kinetically up-regulated following 3 weeks of withdrawal from cocaine self-administration.J. Neurochem. 63,12771281.
  • 26
    Pristupa Z.B., Wilson J.M., Hoffman B.J., Kish S.J. & Niznik H.B. (1994) Pharmacological heterogeneity of the cloned and native human dopamine transporter : disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Mol. Pharmacol. 45,125135.
  • 27
    Reith M.E.A. & Coffey L.L. (1993) Cationic and anionic requirements for the binding of 2β-carbomethoxy-3β-(4-fluorophenyl)[3H]tropane to the dopamine uptake carrier. J. Neurochem. 61,167177.
  • 28
    Reith M.E.A., De Costa B., Rice K.C. & Jacobson A.E. (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter.Eur. J. Pharmacol. 227,417425.
  • 29
    Reith M.E.A., Xu C., Zhang L. & Coffey L.L. (1996) Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter.Naunyn Schmiedebergs Arch. Pharmacol. 354,295304.
  • 30
    Rudnick G. (1997) Mechanisms of biogenic amine neurotransmitter transporters, inNeurotransmitter Transporters : Structure, Function, and Regulation (Reith M. E. A., ed), pp. 73100. Humana Press, Totowa, New Jersey.
  • 31
    Schweri M.M. (1987) Dissimilar effects of halides on [3H]methylphenidate binding and synaptosomal dopamine transport. Soc. Neurosci. Abstr. 13,1111.
  • 32
    Sershen H., Reith M.E.A. & Lajtha A. (1982) Comparison of the properties of central and peripheral binding sites for cocaine.Neuropharmacology 21,469474.
  • 33
    Shank R.P., Schneider C.R. & Tighe J.J. (1987) Ion dependence of neurotransmitter uptake : inhibitory effects of ion substitutes.J. Neurochem. 49,381388.
  • 34
    Shepherd G.M. (1983) Neurobiology. Oxford University Press, New York.
  • 35
    Sonders M.S., Zhu S.J., Zahniser N.R., Kavanaugh M.P. & Amara S.G. (1997) Multiple ionic conductances of the human dopamine transporter : the actions of dopamine and psychostimulants.J. Neurosci. 17,960974.
  • 36
    Sur C., Betz H. & Schloss P. (1997) A single serine residue controls the cation dependence of substrate transport by the rat serotonin transporter.Proc. Natl. Acad. Sci. USA 94,76397644.
  • 37
    Tomlinson G. & Hnatowich M.R. (1988) Apparent competitive inhibition of radioligand binding to receptors : experimental and theoretical considerations in the analysis of equilibrium binding data.J. Recept. Res. 8,809830.
  •  
    Ungell A.L., Oberleithner H., and Graefe K.H. (1989) Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.Naunyn Schmiedebergs Arch. Pharmacol. 339,6570.
  • 39
    Wall S.C., Innis R.B. & Rudnick G. (1993) Binding of the cocaine analog 2β-carbomethoxy-3β-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters : different ionic requirements for substrate and 2β-carbomethoxy-3β-(4-[125I]iodophenyl)tropane binding. Mol. Pharmacol. 43,264270.
  • 40
    Wheeler D.D., Edwards A.M., Chapman B.M. & Ondo J.G. (1994) Effects of cocaine on sodium dependent dopamine uptake in rat striatal synaptosomes.Neurochem. Res. 19,4956.
  • 41
    Wu Q., Coffey L.L. & Reith M.E.A. (1997) Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion. J. Neurochem. 69,11061118.
  • 42
    Xu C., Coffey L.L. & Reith M.E.A. (1995) Translocation of dopamine and binding of 2β-carbomethoxy-3β-(4-fluorophenyl)-tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers. Biochem. Pharmacol. 49,339350.
  • 43
    Xu C., Coffey L.L. & Reith M.E.A. (1997) Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [3H]WIN 35,428 binding. Naunyn Schmiedebergs Arch. Pharmacol. 335,6473.
  • 44
    Zimanyi I., Lajtha A. & Reith M.E.A. (1989) Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum.Naunyn Schmiedebergs Arch. Pharmacol. 340,626632.